Literature DB >> 27019827

Broad-range PCR coupled with mass-spectrometry for the detection of Mycobacterium tuberculosis drug resistance.

Dragoş Florea1, Dan Oţelea2, Ioana D Olaru3, Adriana Hristea1.   

Abstract

BACKGROUND: The need to limit the spread of drug-resistant Mycobacterium tuberculosis requires rapid detection of resistant strains. The present study aimed to evaluate a commercial assay using broad-range PCR coupled with electrospray ionization mass spectrometry (PCR/ESI-MS) for the rapid detection of isoniazid (INH) and rifampin (RIF) resistance in M. tuberculosis strains isolated from Romanian patients with pulmonary tuberculosis.
METHODS: PCR/ESI-MS was used to detect genotypic resistance to RIF and INH in a panel of 63 M. tuberculosis isolates phenotypically characterized using the absolute concentration method on Löwenstein-Jensen medium.
RESULTS: Thirty-eight (60%) strains were susceptible to both drugs, 22 (35%) were RIF and INH resistant, one was INH mono-resistant and two were RIF mono-resistant. The sensitivity for INH and RIF resistance mutations detection were 100% and 92% respectively, with a specificity of more than 95% for each drug.
CONCLUSION: PCR/ESI-MS is a good method for the detection of RIF and INH resistance and might represent an alternative to other rapid diagnostic tests for the detection of genetic markers of resistance in M. tuberculosis isolates.

Entities:  

Keywords:  MDR-TB; Mycobacterium tuberculosis; broad-range PCR; electrospray ionization mass-spectrometry

Year:  2016        PMID: 27019827      PMCID: PMC4788776          DOI: 10.11599/germs.2016.1083

Source DB:  PubMed          Journal:  Germs        ISSN: 2248-2997


  6 in total

1.  Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination.

Authors:  S Sreevatsan; X Pan; K E Stockbauer; N D Connell; B N Kreiswirth; T S Whittam; J M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  TB-Lineage: an online tool for classification and analysis of strains of Mycobacterium tuberculosis complex.

Authors:  Amina Shabbeer; Lauren S Cowan; Cagri Ozcaglar; Nalin Rastogi; Scott L Vandenberg; Bülent Yener; Kristin P Bennett
Journal:  Infect Genet Evol       Date:  2012-03-03       Impact factor: 3.342

3.  Detection of Mycobacterium tuberculosis resistance mutations to rifampin and isoniazid by real-time PCR.

Authors:  A Hristea; D Otelea; S Paraschiv; A Macri; C Baicus; O Moldovan; M Tinischi; V Arama; A Streinu-Cercel
Journal:  Indian J Med Microbiol       Date:  2010 Jul-Sep       Impact factor: 0.985

Review 4.  Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development.

Authors:  Sebastien Gagneux; Peter M Small
Journal:  Lancet Infect Dis       Date:  2007-05       Impact factor: 25.071

5.  Simultaneous identification of mycobacterial isolates to the species level and determination of tuberculosis drug resistance by PCR followed by electrospray ionization mass spectrometry.

Authors:  Christian Massire; Cristina Agasino Ivy; Robert Lovari; Natalia Kurepina; Haijing Li; Lawrence B Blyn; Steven A Hofstadler; George Khechinashvili; Charles W Stratton; Rangarajan Sampath; Yi-Wei Tang; David J Ecker; Barry N Kreiswirth
Journal:  J Clin Microbiol       Date:  2010-12-29       Impact factor: 5.948

6.  Identification of Mycobacterium species and Mycobacterium tuberculosis complex resistance determinants by use of PCR-electrospray ionization mass spectrometry.

Authors:  Patricia J Simner; Seanne P Buckwalter; James R Uhl; Nancy L Wengenack
Journal:  J Clin Microbiol       Date:  2013-08-14       Impact factor: 5.948

  6 in total
  1 in total

1.  Diagnosis of tuberculous pleurisy with combination of adenosine deaminase and interferon-γ immunospot assay in a tuberculosis-endemic population: A prospective cohort study.

Authors:  Han-Yan Xu; Cheng-Ye Li; Shan-Shan Su; Li Yang; Min Ye; Jun-Ru Ye; Pei-Pei Ke; Cheng-Shui Chen; Yu-Peng Xie; Yu-Ping Li
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.